0001127602-12-004603.txt : 20120208 0001127602-12-004603.hdr.sgml : 20120208 20120208130850 ACCESSION NUMBER: 0001127602-12-004603 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120207 FILED AS OF DATE: 20120208 DATE AS OF CHANGE: 20120208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: INGRAM DOUGLAS S CENTRAL INDEX KEY: 0001190644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 12580820 MAIL ADDRESS: STREET 1: 2525 DUPONT DR CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 4 1 form4.xml PRIMARY DOCUMENT X0304 4 2012-02-07 0000850693 ALLERGAN INC AGN 0001190644 INGRAM DOUGLAS S 2525 DUPONT DRIVE IRVINE CA 92612 1 EVP and President, EAME Common Stock 2012-02-07 4 M 0 66000 41.24 A 89814.176 D Common Stock 2012-02-07 4 S 0 66000 86.3747 D 23814.176 D Common Stock 2662.2215 I By 401(k) Trust Common Stock 3596.7989 I By Esop Trust Employee Stock Option (Right to Buy) 41.24 2012-02-07 4 M 0 66000 0 D 2014-01-30 Common Stock 66000 0 D The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $86.25 to $86.53, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan. Shares allocated to reporting person's SIP account as of reporting date. Shares allocated to the reporting person's ESOP account as of reporting date. The option becomes exercisable in four equal annual installments beginning January 30, 2005. /s/ Matthew J. Maletta, attorney-in-fact for Douglas S. Ingram 2012-02-07